Autophagy in breast cancer metastatic dormancy: tumor suppressing or tumor promoting functions?

Abstract

Breast cancer is the second leading cause of cancer-associated death in women in the United States, with more than 90% of those deaths attributed to metastasis. Breast cancer metastasis is incurable and possesses few treatment options and a poor overall prognosis due in part to confounding metastatic attributes, particularly the acquisition of dormancy-associated phenotypes. Dormant disseminated tumor cells can persist for years-to-decades before recurring as highly aggressive, secondary lesions. Dormancy-associated phenotypes are exhibited by breast cancer stem cells (BCSCs), which undergo tumor initiation and unlimited self-renewal. In addition to their specialized abilities to circumvent chemotherapeutic insults, BCSCs also upregulate autophagy during metastatic dormancy as a means to survive in nutrient poor conditions and environmental stress. As such, therapeutic targeting of autophagy is actively being pursued as an attractive strategy to alleviate metastatic disease and the recurrence of dormant BCSCs. Here we review the molecular and cellular features of autophagy, as well as its paradoxical role in both suppressing and promoting mammary tumor development and metastatic progression. Finally, we highlight the clinical challenges associated with therapeutic targeting of autophagy in metastatic breast cancers.

Keywords

Autophagy / breast cancer / cancer stem cells / metastatic dormancy / metastatic relapse

References

[1] Siegel RL,Jemal A.Cancer statistics, 2018..CA Cancer J Clin2018;68:7-30

[2] O'Shaughnessy J.Extending survival with chemotherapy in metastatic breast cancer..Oncologist.2005;10 Suppl 3:20-9

[3] Cardoso F,Fallowfield L,Senkus E.Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up..Ann Oncol.2012;23 Suppl 7:vii11-9

[4] Foulkes WD,Reis-Filho JS.Triple-negative breast cancer..N Engl J Med2010;363:1938-48

[5] Sosa MS,Aguirre-Ghiso JA.Mechanisms of disseminated cancer cell dormancy: an awakening field..Nat Rev Cancer2014;14:611-22 PMCID:PMC4230700

[6] Yoshida BA,Welch DR.Metastasis-suppressor genes: a review and perspective on an emerging field..J Natl Cancer Inst2000;92:1717-30

[7] Cowin P.Breast cancer progression: controversies and consensus in the molecular mechanisms of metastasis and EMT..J Mammary Gland Biol Neoplasia2007;12:99-102 PMCID:PMC1963418

[8] Taylor DP,Savol A,Wells A.Modeling boundary conditions for balanced proliferation in metastatic latency..Clin Cancer Res2013;19:1063-70 PMCID:PMC3594128

[9] Wells A,Wells JZ.The dormancy dilemma: quiescence versus balanced proliferation..Cancer Res2013;73:3811-6 PMCID:PMC3702639

[10] Gao H,Lee-Lim AP,Decker M.The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites..Cell2012;150:764-79 PMCID:PMC3711709

[11] Chao YL,Wells A.Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition..Mol Cancer2010;9:179 PMCID:PMC2907333

[12] Marshall JC,Nakayama J,Liewehr DJ.Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer..J Natl Cancer Inst2012;104:1306-19 PMCID:PMC3611817

[13] Klein CA.Framework models of tumor dormancy from patient-derived observations..Curr Opin Genet Dev2011;21:42-9

[14] Demicheli R,Miceli R,Bonadonna G.Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy..Breast Cancer Res Treat1996;41:177-85

[15] Hensel JA,Theodorescu D.Clinical opportunities and challenges in targeting tumour dormancy..Nat Rev Clin Oncol2013;10:41-51

[16] Carcereri de Prati A,Rigo A,Rossin M.Metastatic Breast Cancer Cells Enter Into Dormant State and Express Cancer Stem Cells Phenotype Under Chronic Hypoxia..J Cell Biochem2017;118:3237-48

[17] Mathew R,Beaudoin B,Chen G.Autophagy suppresses tumorigenesis through elimination of p62..Cell2009;137:1062-75 PMCID:PMC2802318

[18] Mowers EE,Macleod KF.Autophagy in cancer metastasis..Oncogene2017;36:1619-30 PMCID:PMC5337449

[19] Prager BC,Bao S.Cancer stem cells: the architects of the tumor ecosystem..Cell Stem Cell2019;24:41-53 PMCID:PMC6350931

[20] Ding L,Li S,Chen K.Genome remodelling in a basal-like breast cancer metastasis and xenograft..Nature2010;464:999-1005 PMCID:PMC2872544

[21] Yates LR,Knappskog S,Gundem G.Subclonal diversification of primary breast cancer revealed by multiregion sequencing..Nat Med2015;21:751-9 PMCID:PMC4500826

[22] Shah SP,Khattra J,Pugh T.Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution..Nature2009;461:809-13

[23] Savas P,Lefevre C,Caramia F.The subclonal architecture of metastatic breast cancer: results from a prospective community-based rapid autopsy program "CASCADE"..PLoS Med2016;13:e1002204 PMCID:PMC5189956

[24] Wendt MK,Schiemann BJ.Downregulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer..Mol Bio cell2011;22:2423-35 PMCID:PMC3135469

[25] Gooding AJ,Jahanbani FK,Chang JC.The lncRNA BORG drives breast cancer metastasis and disease recurrence..Sci Rep2017;7:12698 PMCID:PMC5629202

[26] Dean M.ABC transporters, drug resistance, and cancer stem cells..J Mammary Gland Biol Neoplasia2009;14:3-9

[27] Donnenberg VS,Donnenberg AD.Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells..Methods Mol Biol2009;568:261-79 PMCID:PMC4165075

[28] Hawley TS,Yang W,Depalma L.Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1..Am J Hematol2013;88:265-72 PMCID:PMC3608751

[29] Todaro M,Di Stefano AB,Vermeulen L.Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4..Cell Stem Cell2007;1:389-402

[30] Diehn M,Lobo NA,Dorie MJ.Association of reactive oxygen species levels and radioresistance in cancer stem cells..Nature2009;458:780-3 PMCID:PMC2778612

[31] Zou Z,Zhang Q,Chen J.Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells..Autophagy2012;8:1798-810 PMCID:PMC3541289

[32] White E,Chan CS.Autophagy, metabolism, and cancer..Clin Cancer Res2015;21:5037-46 PMCID:PMC4646728

[33] Rogov V,Johansen T.Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy..Mol Cell2014;53:167-78

[34] Galluzzi L,Bravo-San Pedro JM,Baehrecke EH.Autophagy in malignant transformation and cancer progression..EMBO J2015;34:856-80 PMCID:PMC4388596

[35] Thorburn A,Gustafson DL.Autophagy and cancer therapy..Mol Pharmacol2014;85:830-8 PMCID:PMC4014668

[36] Kimmelman AC.The dynamic nature of autophagy in cancer..Genes Dev2011;25:1999-2010 PMCID:PMC3197199

[37] Liang XH,Seaman M,Kempkes B.Induction of autophagy and inhibition of tumorigenesis by beclin 1..Nature1999;402:672-6

[38] Yue Z,Yang C,Heintz N.Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor..Proc Natl Acad Sci U S A2003;100:15077-82 PMCID:PMC299911

[39] Qu X,Bhagat G,Hibshoosh H.Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene..J Clin Invest2003;112:1809-20 PMCID:PMC297002

[40] Komatsu M,Waguri S,Kobayashi A.The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1..Nat Cell Biol2010;12:213-23

[41] Lau A,Zhao F,Wu T.A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62..Mol Cell Biol2010;30:3275-85 PMCID:PMC2897585

[42] Villeneuve NF,Zhang DD.Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases..Antioxid Redox Signal2010;13:1699-712 PMCID:PMC2966484

[43] Hayes JD.NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer..Trends Biochem Sci2009;34:176-88

[44] Mathew R,Beaudoin B,Bray K.Autophagy suppresses tumor progression by limiting chromosomal instability..Genes Dev2007;21:1367-81 PMCID:PMC1877749

[45] Liu EY,O'Prey J,Joshi S.Loss of autophagy causes a synthetic lethal deficiency in DNA repair..Proc Natl Acad Sci U S A2015;112:773-8 PMCID:PMC4311830

[46] Gillespie DA.Autophagy is critically required for DNA repair by homologous recombination..Mol Cell Oncol2016;3:e1030538 PMCID:PMC4845186

[47] Massague J.Metastatic colonization by circulating tumour cells..Nature2016;529:298-306 PMCID:PMC5029466

[48] Wyckoff JB,Condeelis JS.A critical step in metastasis: in vivo analysis of intravasation at the primary tumor..Cancer Res2000;60:2504-11

[49] Chambers AF,MacDonald IC.Dissemination and growth of cancer cells in metastatic sites..Nat Rev Cancer2002;2:563-72

[50] Janji B,Moussay E,Arakelian T.The multifaceted role of autophagy in tumor evasion from immune surveillance..Oncotarget2016;7:17591-607 PMCID:PMC4951235

[51] Degenhardt K,Beaudoin B,Anderson D.Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis..Cancer Cell2006;10:51-64 PMCID:PMC2857533

[52] Karantza-Wadsworth V,Kravchuk O,Mathew R.Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis..Genes Dev2007;21:1621-35 PMCID:PMC1899472

[53] Fung C,Gao S,Debnath J.Induction of autophagy during extracellular matrix detachment promotes cell survival..Mol Biol Cell2008;19:797-806 PMCID:PMC2262959

[54] Cufi S,Oliveras-Ferraros C,Vellon L.Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype..Cell Cycle2011;10:3871-85

[55] Vera-Ramirez L,Nini R,Green JE.Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence..Nat Commun2018;9:1944 PMCID:PMC5964069

[56] Yu H,Pardoll D.Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment..Nat Rev Immunol2007;7:41-51

[57] Kortylewski M,Wang T,Zhang S.Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity..Nat Med2005;11:1314-21

[58] Baginska J,Berchem G,Noman MZ.Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia..Proc Natl Acad Sci U S A2013;110:17450-5 PMCID:PMC3808626

[59] Viry E,Berchem G,Medves S.Autophagic degradation of GZMB/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis..Autophagy2014;10:173-5 PMCID:PMC4389872

[60] Taylor MA,Schiemann WP.The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells..J Mammary Gland Biol Neoplasia2010;15:169-90 PMCID:PMC3721368

[61] Ricciardi M,Malpeli G,Perbellini O.Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells..Br J Cancer2015;112:1067-75 PMCID:PMC4366889

[62] Akalay I,Hasmim M,Andre F.Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis..Cancer Res2013;73:2418-27

[63] Akalay I,Hasmim M,Thiery JP.EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction..Autophagy2013;9:1104-6 PMCID:PMC3722321

[64] Aguirre-Ghiso JA.Models, mechanisms and clinical evidence for cancer dormancy..Nat Rev Cancer2007;7:834-46 PMCID:PMC2519109

[65] Chaffer CL,Lim E.EMT, cell plasticity and metastasis..Cancer Metastasis Rev2016;35:645-54

[66] Semenza GL.Hypoxia-inducible factors in physiology and medicine..Cell2012;148:399-408 PMCID:PMC3437543

[67] Whelan KA,Tanaka K,Guha M.Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance..Oncogene2017;36:4843-58 PMCID:PMC5570661

[68] Zhang XH,Gerald W,Norton L.Latent bone metastasis in breast cancer tied to Src-dependent survival signals..Cancer Cell2009;16:67-78 PMCID:PMC2749247

[69] Lee IH,Fergusson MM,Bishop AJ.Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress..Science2012;336:225-8 PMCID:PMC4721513

[70] Lum JJ,Kong M,Li C.Growth factor regulation of autophagy and cell survival in the absence of apoptosis..Cell2005;120:237-48

[71] Lu Z,Lu Y,Yu Q.The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells..J Clin Invest2008;118:3917-29 PMCID:PMC2582930

[72] Kimura T,Takahashi A.Chloroquine in cancer therapy: a double-edged sword of autophagy..Cancer Res2013;73:3-7

[73] Maycotte P,Cummings CT,Morgan MJ.Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy..Autophagy2012;8:200-12 PMCID:PMC3336076

[74] Wang H,Jiang Z,Wang Z.Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis..Sci Rep2016;6:26456 PMCID:PMC4877646

[75] Gavilan E,Sanchez-Aguayo I,Ruano D.Breast cancer cell line MCF7 escapes from G1/S arrest induced by proteasome inhibition through a GSK-3beta dependent mechanism..Sci Rep2015;5:10027 PMCID:PMC4419540

[76] Milani M,Mellor HR,Bottini A.The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib..Cancer Res2009;69:4415-23

[77] Boya P,Poncet D,Vieira HL.Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine..Oncogene2003;22:3927-36

[78] Choi DS,Kim YS,Zhao H.Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1..Stem Cells2014;32:2309-23 PMCID:PMC4138251

[79] Royce ME.Everolimus in the Treatment of Metastatic Breast Cancer..Breast Cancer (Auckl)2015;9:73-9 PMCID:PMC4571987

[80] Vinayak S.mTOR inhibitors in the treatment of breast cancer..Oncology (Williston Park)2013;27:38-446, 8 passim

[81] Ellard SL,Gelmon KA,Kennecke H.Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163..J Clin Oncol2009;27:4536-41

[82] Fleming GF,Huo D,Tretiakova M.Phase II trial of temsirolimus in patients with metastatic breast cancer..Breast Cancer Res Treat2012;136:355-63 PMCID:PMC3658119

[83] Liu Y,Sumpter RM, Jr.,Ginet V.Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia..Proc Natl Acad Sci U S A2013;110:20364-71 PMCID:PMC3870705

[84] Pavlides S,Migneco G,Chiavarina B.The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism..Cell Cycle2010;9:3485-505 PMCID:PMC3047615

[85] Martinez-Outschoorn UE,Lin Z,Chiavarina B.Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFkappaB activation in the tumor stromal microenvironment..Cell Cycle2010;9:3515-33 PMCID:PMC3047617

[86] Sotgia F,Howell A,Pavlides S.Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms..Annu Rev Pathol2012;7:423-67